← Insider buys
RYTM

Rhythm Pharmaceuticals, Inc. · Healthcare

Chief Technical Officer Joseph Shulman sold $3.7M of Rhythm Pharmaceuticals, Inc.

Sold$3,680,198
$50.39Price
73,038Shares
−96%Stake

What RYTM did after the filing

Prices for RYTM after this filing aren't in yet.

Traded Fri, Feb 9. Filed Tue, Feb 13, 3:46 PM ET, during the session. Not investment advice.